January 24, 2020
TOPIC: Featured News, Patients & Members
NORD Launches New Patient Assistance Program Providing Support to Eligible NMOSD Patients
Posted at January 1, 2020 11:40 am by Laura Mullen
January 23, 2020
TOPIC: Featured News, Medical, Patients & Members, Press Releases, Research
NORD Joins with Pyruvate Kinase Deficiency Community to Publish Historic “Voice of the Patient” Report
Posted at January 1, 2020 02:29 pm by Laura Mullen
Washington, DC, January 23, 2020–The National Organization for Rare Disorders (NORD)®, the Foundation for Rare Blood Diseases (SZB) and the pyruvate kinase deficiency community together made history on September 20, 2019 with patients and families sharing their experiences directly with the US Food and Drug Administration (FDA) and other key stakeholders, and first-of-its-kind testimony from the heavily impacted Amish… Read More
January 20, 2020
TOPIC: Featured News, Patients & Members
NORD Reaches 300 Members!
Posted at January 1, 2020 08:00 am by Laura Mullen
At NORD we are extremely proud to welcome our 300th member organization! Our Odyssey is a national nonprofit supporting chronic and rare disease young adult patients by providing social and emotional support in the hope of improving their quality of life. Not only is Our Odyssey the 300
January 17, 2020
TOPIC: Advocacy, Featured News, Patients & Members
Head of the Herd: Leah Schust Myers, FamilieSCN2A Foundation
Posted at January 1, 2020 08:35 am by Laura Mullen
At the head of the herd is… Leah Schust Myers, Founder, Executive Director and Research Committee Chair, FamilieSCN2A Foundation
Leah advocates for those living with… SCN2A Disorders
Leah is located in… Gettysburg, PA
How Leah got here…
My son had his first seizure a few days after his first birthday. Our… Read More
January 7, 2020
TOPIC: Featured News, Patients & Members, Sticky Posts for Homepage
NORD Survey to Better Understand Rare Disease Diagnosis, Care and Treatment in the US: Take Part in Our 30 Year Follow-up
Posted at January 1, 2020 08:08 am by Laura Mullen
At NORD, our priority is advancing rare disease research and innovation by working together to overcome critical challenges. The input of patients and caregivers plays an integral role in getting beyond obstacles and moving towards a brighter future for the rare disease community.
In… Read More
